In vitro and ex vivo, untreated HIV is associated with accumulation of intracellular cholesterol in monocyte/macrophages (M/M) and impaired cholesterol efflux, both of which may impact on atherogenesis and cardiovascular disease (CVD) risk. We aimed to prospectively examine the effect of antiretroviral therapy (ART) initiation on monocyte cholesterol metabolism in vivo.
In a multi-centre, prospective study, 28 genes involved in regulation of monocyte cholesterol metabolism (sensing, uptake, endogenous cholesterol synthesis and efflux), inflammation and mitochondrial function were measured using quantitative PCR arrays in RNA extracted from monocytes derived from ART-naïve adults at baseline and at 4 and 12 weeks post ART initiation. Data are presented as median (IQR), with genes expressed as a ratio to three housekeeping genes (ACTB, TBP, RPL13). Within- and between-group (PI/non-PI) differences were compared using Wilcoxon signed rank and Mann-Whitney U tests respectively.
Of 85 HIV-positive subjects, (median (IQR) age 37 (31, 44) years, 70 (82%) male, 62 (73%) Caucasian, CD4+ T-cell count 369 (297, 547) cells/mm3, HIV RNA 42,181 (19,474, 107,593) copies/ml), 30 (35%) initiated protease inhibitor (PI) based regimens. ART initiation was accompanied by a coordinated downregulation of cholesterol sensing (SREBF1, SREBF2), uptake (LDLR) and endogenous cholesterol synthesis (HMGCR, PMVK, ACAT2) genes at weeks 4 and 12 consistent with appropriate intracellular responses to increased availability of intracellular cholesterol (table 1). However, cholesterol efflux pathways were dysregulated, with expression of ABCA1 and its regulators (NR1H3 and PPARα) downregulated while SR-B1 gene expression, indicative of an alternative efflux pathway, was upregulated (table 1). ART initiation was accompanied by an expected downregulation of inflammatory pathway genes (TLR4, NFκB1 and NLRP3, all p<0.05) and increased expression of mitochondrial RNA (MT-CTB, p<0.01). There was no significant difference in the pattern of gene expression changes with initiation of PI versus non-PI based ART.
This, the first study to prospectively examine M/M gene expression, demonstrates a molecular signature consistent with further increased availability of intracellular cholesterol and disrupted cholesterol efflux pathways with ART initiation despite expected appropriate downregulation of inflammatory pathways. How these changes impact on CVD risk remains to be determined.